Florida's healthcare system is not just struggling — by independent measures, it is among the worst in the country. The 2025 Commonwealth Fund State Health System Performance Scorecard ranked Florida 39th overall, with 10.7% of residents uninsured compared to a 7.9% national average, and 14.4% of adults reporting they went without needed medical care due to cost. An estimated 315,000 Floridians sit in the coverage gap — earning too much for traditional Medicaid but too little for Affordable Care Act subsidies.

These numbers are not abstractions. They are the mathematical result of policy choices — and her platform is built on the argument that only direct intervention can reverse them.

The contrast with her Republican opponent, incumbent Senator Ashley Moody, could not be starker. Where Nixon proposes federal mandates and direct funding, Moody champions market competition, deregulation, and spending discipline. The race has become a referendum on two fundamentally different theories of how government should confront a failing system.

The Medicaid Expansion Question

Nixon has served in the Florida House since 2020 and has consistently criticized state leadership for refusing to expand Medicaid under the Affordable Care Act. Her argument is straightforward: the federal government covers 90% of expansion costs, and Florida leaves roughly $4 billion to $5 billion in federal funds on the table annually by opting out. Economists at groups like the Florida Policy Institute have calculated that this forgone revenue starves the state's healthcare infrastructure while leaving hundreds of thousands of lower-income residents uninsured.

While a U.S. Senator cannot force Florida to expand Medicaid — that power rests with the governor and state legislature under the Constitution — Nixon can advocate for federal incentives and use her platform to pressure Tallahassee. Her campaign frames the coverage gap as a political failure, not an inevitability.

Medicare for All: Bypassing State Resistance

Nixon's signature proposal goes further than Medicaid expansion. She explicitly advocates for a single-payer government plan covering all Americans with no premiums, deductibles, or copays — framing medical care as a fundamental human right rather than a commercial privilege.

The strategic logic is direct: if Florida's state government refuses to expand coverage, a federal Medicare for All system would bypass that resistance entirely. A senator votes on structural federal plans, and if passed nationally, such a bill would fundamentally replace or alter private insurance and public programs across every state — including Florida.

Critics label the plan "socialism" and financially unsustainable. Nixon pushes back, describing herself as "a humanist who cares about people" and arguing that universal healthcare would actually reduce the national debt by preventing emergency room reliance — a point that resonates in a state where uncompensated hospital costs are driven by uninsured residents seeking routine care in emergency departments.

Funding the System

Nixon's platform includes capping prescription drug costs and implementing a wealth tax on billionaires to fund universal healthcare services. While a senator cannot single-handedly set prices, federal lawmakers can pass laws capping out-of-pocket costs for medications like insulin and allowing Medicare to negotiate lower drug prices across the board.

The funding mechanism — a wealth tax — faces steep hurdles in a divided Congress, requiring majority support from colleagues representing all 50 states. But Nixon frames it as a matter of priorities: the question is not whether the country can afford universal care, but whether it can afford not to.

Nixon has proposed expanding VA medical infrastructure — including building a full VA medical center in Jacksonville — and auto-enrolling new veterans into comprehensive dental and vision care. It is among her most specific and tangible proposals, a direct government investment in facilities and services rather than a regulatory adjustment.

The proposal reflects the broader philosophical divide in the race. Where Moody's platform removes barriers and hopes private capital responds, Nixon's platform funds and builds. One approach invites supply by creating legal conditions for expansion; the other creates supply by actively funding the infrastructure itself.

The Safety Nets

The candidates also clash over regulation itself. Nixon and public health advocates argue that strict FDA pipelines are the primary barrier preventing toxic or ineffective medications from entering the market, and that Certificate of Need laws — which require providers to prove a mathematical "need" before building — prevent hospital conglomerates from over-building in wealthy areas while ignoring rural and low-income regions. Without these guidelines corporate networks prioritize lucrative elective procedures over essential public health infrastructure, diluting an already scarce supply of nurses and doctors across more facilities.

Moody's defenders counter that removing construction barriers forces hospitals to compete on both price and quality. They point to Florida's 2019 phased repeal of Certificate of Need laws for general hospitals, after which major new facilities — UCF Lake Nona Hospital, Sarasota Memorial Hospital Venice, and HCA Florida University Hospital — were built to match population growth, and no existing hospitals closed. Free-market advocates also cite data showing states without CON laws maintain significantly higher per-capita intensive care and neonatal capacity, reducing emergency room overcrowding that drives cross-infections and staff burnout.

But deregulation does not build a single hospital bed — it merely grants permission for corporations to build where profit margins are highest. In a severe national staffing shortage, opening more buildings simply reshuffles a finite supply of healthcare workers from one facility to another, driving up labor costs without increasing the system's overall capacity.

Why Direct Action Is the Realistic Path

Strip away the labels and the core dispute is about realism. Nixon's critics call her agenda "socialism," but her mechanisms are concrete and have precedent: Medicaid expansion is already law in 40 states, and federal subsidy and price-negotiation programs already exist in statute. The federal government already negotiates drug prices for Medicare, already sets ACA subsidy rates, and already funds the VA hospital system. Nixon's proposals scale up tools that are already operating — they do not invent a new economic physics.

The market-based alternative rests on a different wager: that removing regulatory barriers will reliably produce affordable care in the places that need it. Florida's own record complicates that bet. The state has spent years declining federal expansion money and, as of the 2025 scorecard, still ranks 39th — with an uninsured rate roughly three points above the national average and 315,000 residents stranded in the coverage gap. If deregulation and competition were the answer, the state's numbers would show it by now.

The deeper problem is that medical demand is inelastic: a patient cannot decline insulin or emergency surgery because the price rose. In a market where consumers cannot walk away, supply-side competition has a weak lever — especially in rural and low-income areas where profit margins are thin and private capital rarely follows. That is the gap Nixon's platform targets directly, through federal funding and mandates rather than hoping incentives eventually align with public need.

Defenders of Moody's approach counter that direct government expansion creates open-ended fiscal liabilities, pointing to states where Medicaid enrollment outpaced projections and healthcare now consumes roughly 30% of Florida's state budget. They argue that spending discipline and fraud enforcement are the mathematically sustainable path. But even granting that fiscal concern, it describes a cost risk — not a coverage mechanism. It does not explain how the 315,000 people in the gap obtain care, or how rural counties without a delivery ward or ICU acquire one.

That asymmetry is the heart of Nixon's case: her plan changes the economics by law, while her opponent's plan changes the rules and waits to see whether the economics follow. In a state ranked near the bottom nationally, "wait and see" is a hard sell.

Ultimately, the race presents voters with a fundamental choice: Nixon's platform of universal, guaranteed healthcare versus Moody's platform of market competition. Florida's dismal rankings are proof the current system is broken — and that the only permanent fix is direct action to bypass state-level resistance. Whether voters agree will be decided on November 3.